Abstract:Mammalian cell expression systems are the most commonly used platforms for producing biotherapeutic proteins. However, development of recombinant mammalian cell lines is often hindered by the unstable and variable transgene expression associated with random integration. We have developed an efficient strategy for site-specific integration of genes of interest (GOIs). This method enables rapid and precise insertion of a gene expression cassette at defined loci in mammalian cells, resulting in homogeneous transgene expression. We identified the Hipp11 (H11) gene as a "safe harbor" locus for gene knock-in in CHO-S cells. Using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 mediated homologous recombination, we knocked in a DNA cassette (the landing pad) that includes a pair of PhiC31 bacteriophage attP sites and genes facilitating integrase-based GOI integration. A master cell line, with the landing pad inserted correctly in the H11 locus, was established. This master cell line was used for site-specific, irreversible recombination, catalyzed by PhiC31 integrase. Using this system, an integration efficiency of 97.7% was achieved with green fluorescent protein (GFP) after selection. The system was then further validated in HEK293T cells, using an analogous protocol to insert the GFP gene at the ROSA26 locus, resulting in 90.7% GFP-positive cells after selection. In comparison, random insertion yielded 0.68% and 1.32% GFP-positive cells in the CHO-S and HEK293T cells, respectively. Taken together, these findings demonstrated an accurate and effective protocol for generating recombinant cell lines to provide consistent protein production. Its likely broad applicability was illustrated here in two cell lines, CHO-S and HEK293T, using two different genomic loci as integration sites. Thus, the system is potentially valuable for biomanufacturing therapeutic proteins.

A Precise and Sustainable Doxycycline-Inducible Cell Line Development Platform for Reliable Mammalian Cell Engineering with Gain-of-Function Mutations

A single plasmid transfection that offers a significant advantage associated with puromycin selection, fluorescence-assisted cell sorting, and doxycycline-inducible protein expression in mammalian cells

Establishment and detection of a Tet-off stable cell line expressing Egr-1 protein regulated by doxycycline

A synthetic transcription platform for programmable gene expression in mammalian cells

Simple piggyBac transposon-based mammalian cell expression system for inducible protein production

A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control

Development of potent in vivo mutagenesis plasmids with broad mutational spectra

A system for site-specific integration of transgenes in mammalian cells

A chimeric viral platform for directed evolution in mammalian cells

A Platform For Rapid Prototyping Of Synthetic Gene Networks In Mammalian Cells

Cell-Free Optogenetic Gene Expression System

Construction of an Inducible Stable Cell Line for Efficient Incorporation of Unnatural Amino Acids in Mammalian Cells.

Systematic Transfer of Prokaryotic Sensors and Circuits to Mammalian Cells

Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors

Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression

High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors

Small-molecule inducible transcriptional control in mammalian cells

An improved tetracycline-inducible expression system for fission yeast

Reversal of the silencing of tetracycline-controlled genes requires the coordinate action of distinctly acting transcription factors